Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Total Liabilities (2016 - 2025)

Pediatrix Medical (MD) has disclosed Total Liabilities for 17 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities changed 0.5% to $1.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 billion, a 0.5% change, with the full-year FY2025 number at $1.4 billion, changed 0.5% from a year prior.
  • Total Liabilities was $1.4 billion for Q4 2025 at Pediatrix Medical, up from $1.3 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.8 billion in Q4 2021 to a low of $1.2 billion in Q1 2025.
  • A 5-year average of $1.5 billion and a median of $1.4 billion in 2024 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: plummeted 39.39% in 2021, then rose 1.24% in 2024.
  • Pediatrix Medical's Total Liabilities stood at $1.8 billion in 2021, then decreased by 20.24% to $1.5 billion in 2022, then decreased by 5.87% to $1.4 billion in 2023, then rose by 1.24% to $1.4 billion in 2024, then decreased by 0.5% to $1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for MD's Total Liabilities are $1.4 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025).